Julius Brennecke

Last updated

Julius Brennecke (born 1975) is a German molecular biologist and geneticist. He is a Senior Group Leader at the Institute of Molecular Biotechnology. [1] (IMBA) of the Austrian Academy of Sciences in Vienna.

Contents

Education and career

Julius Brennecke studied biology at Heidelberg University. [2] During his diploma thesis (supervised by Dirk Bohmann) he focused on the tandem affinity purification of protein complexes in Drosophila. In his PhD-thesis (with Steve Cohen), he specialized on microRNAs and their regulatory targets in Drosophila.

He obtained his PhD degree in 2005 (summa cum laude) from Heidelberg University jointly with the European Molecular Biology Laboratory (EMBL). After a short postdoctoral stay at EMBL, he carried out his postdoctoral training with Gregory Hannon at the Cold Spring Harbor Laboratory in New York (2006 to 2008). [3] In 2009 he became group leader at the Institute of Molecular Biotechnology, part of the Vienna BioCenter, where he was appointed Senior Group Leader in 2014. Brennecke is a permanent EMBO member [4] and editorial board member of the Journal of Cell Biology . [5]

In 2020, Brennecke and his team significantly contributed to improving the RT-LAMP technique to support testing and detection of SARS-CoV-2 in Austria. [6] In October 2020, the AGES (Austrian Agency for Health and Food Safety) explicitly recommended this technique for application in hospitals and diagnostic laboratories. [7] [8] This successful project was a collaboration between Brennecke and scientists from the Institute of Molecular Pathology in Vienna.

Research

In his research Brennecke [9] [10] focuses on small regulatory RNA pathways (foremost the piRNA/Piwi pathway) and their role in suppressing transposable elements and inducing heterochromatin formation in animals. His research group focuses on the model organism Drosophila melanogaster and applies diverse approaches, such as genetics, genomics, biochemistry, imaging technologies, and computational biology.   

Selected publications

Hayashi, R., Schnabl, J., Handler, D., Mohn, F., Ameres, SL., Brennecke, J.: Genetic and mechanistic diversity of piRNA 3‘-end formation. Nature (2016) DOI: 10.1038/nature20162

Andersen, PR., Tirian, L., Vunjak, M., Brennecke, J.: A heterochromatin-dependent transcription machinery drives piRNA expression. Nature (2017) DOI: 10.1038/nature23482

Mohn, F., Handler, D., Brennecke, J.: Noncoding RNA. piRNA- guided slicing specifies transcripts for Zucchini-dependent, phased piRNA biogenesis. Science (2015) DOI: 10.1126/science.aaa1039

Awards and honours

Related Research Articles

<span class="mw-page-title-main">European Molecular Biology Laboratory</span> Molecular biology research institution

The European Molecular Biology Laboratory (EMBL) is an intergovernmental organization dedicated to molecular biology research and is supported by 28 member states, one prospect state, and one associate member state. EMBL was created in 1974 and is funded by public research money from its member states. Research at EMBL is conducted by approximately 110 independent research and service groups and teams covering the spectrum of molecular biology and bioinformatics. The list of Groups and Teams at EMBL can be found at www.embl.org. The Laboratory operates from six sites: the main laboratory in Heidelberg, and sites in Hinxton, Grenoble (France), Hamburg (Germany), Rome (Italy) and Barcelona (Spain). EMBL groups and laboratories perform basic research in molecular biology and molecular medicine as well as train scientists, students, and visitors. The organization aids in the development of services, new instruments and methods, and technology in its member states. Israel is the only full member state located outside Europe.

<span class="mw-page-title-main">European Molecular Biology Organization</span> Organization of researchers in the life science

The European Molecular Biology Organization (EMBO) is a professional, non-profit organization of more than 1,800 life scientists. Its goal is to promote research in life science and enable international exchange between scientists. It co-funds courses, workshops and conferences, publishes five scientific journals and supports individual scientists. The organization was founded in 1964 and is a founding member of the Initiative for Science in Europe. As of 2022 the Director of EMBO is Fiona Watt, a stem cell researcher, professor at King's College London and a group leader at the European Molecular Biology Laboratory.

<span class="mw-page-title-main">Matthias Hentze</span> German scientist

Matthias Werner Hentze is a German scientist. He is the director of the European Molecular Biology Laboratory (EMBL), co-director of the Molecular Medicine Partnership Unit between EMBL and Heidelberg University, and Professor of Molecular Medicine at Heidelberg University.

<span class="mw-page-title-main">Research Institute of Molecular Pathology</span>

The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.

<span class="mw-page-title-main">Institute of Molecular Biotechnology</span> Austrian biomedical research organisation

The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.

<span class="mw-page-title-main">Max Perutz Labs</span>

The Max Perutz Labs Vienna are a molecular biology research centre operated jointly by the University of Vienna and the Medical University of Vienna located at the Vienna Biocenter. The institute is named after the Viennese-born biochemist and Nobel laureate Max Ferdinand Perutz. On average, the institute hosts 50 independent research groups. Max Perutz Labs scientists participate in the undergraduate curricula for students of the University of Vienna and the Medical University of Vienna.

Ruth Lehmann is a developmental and cell biologist. She is the Director of the Whitehead Institute for Biomedical Research, succeeding David Page. She previously was affiliated with the New York University School of Medicine, where she was the Director of the Skirball Institute of Biomolecular Medicine, the Laura and Isaac Perlmutter Professor of Cell Biology, and the Chair of the Department of Cell Biology. Her research focuses on germ cells and embryogenesis.

<span class="mw-page-title-main">Thomas Jenuwein</span> German scientist

Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.

<span class="mw-page-title-main">Barry Dickson</span> Australian neurobiologist

Barry J. Dickson is an Australian neurobiologist who studies the development of neuronal networks in the fruit fly Drosophila melanogaster. Dickson is a group leader at the Janelia Research Campus of the Howard Hughes Medical Institute in Loudoun County, Virginia and a former scientific director of the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.

<span class="mw-page-title-main">Denise P. Barlow</span> British geneticist

Denise P. Barlow was a British geneticist who worked in the field of epigenomics. Barlow was an elected member of European Molecular Biology Organization (EMBO), an honorary professor of genetics at the University of Vienna and recipient of the Erwin Schrödinger Prize of the Austrian Academy of Sciences. In 1991, she discovered the first mammalian imprinted gene, IGF2R, which codes for the insulin-like growth factor.

Alexander Stark is a biochemist and computational biologist working on the regulation of gene expression in development. He is a senior scientist at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter and adjunct professor of the Medical University of Vienna.

<span class="mw-page-title-main">Jan O. Korbel</span> German scientist

Jan O. Korbel is a German scientist working in the fields of Human Genetics, Genomics and Computational Biology. He is a tenured principal investigator and Head of Data Science at the European Molecular Biology Laboratory Heidelberg, Germany, senior scientist in the Genome Biology Unit, is leading a bridging research division at the German Cancer Research Center (DKFZ), and is an honorary professor ("Honorarprofessor") at Heidelberg University. A particular focus of the Korbel group is on investigating a particular form of mutation, genomic structural variation, which includes deletions, inversions and more complex chromosomal rearrangements such as chromothripsis events that can occur in healthy individuals and in context of disease. His group's principal research objective is to understand genomic structural variations as a basis of phenotypic variation and cancer development.

<span class="mw-page-title-main">Melina Schuh</span> German molecular biologist

Melina Schuh is a German biochemist and Director at the Max Planck Institute for Multidisciplinary Sciences. She is known for her work on meiosis in mammalian oocytes, for her studies on the mechanisms leading to the age-related decline in female fertility, and for the development of the Trim-Away protein depletion method.

Antonio Jesus Giraldez is a Spanish developmental biologist and RNA researcher at Yale University School of Medicine, where he serves as chair of the department of genetics and Fergus F. Wallace Professor of Genetics. He is also affiliated with the Yale Cancer Center and the Yale Stem Cell Center.

Asifa Akhtar is a Pakistani biologist who has made significant contributions to the field of chromosome regulation. She is Senior Group Leader and Director of the Department of Chromatin Regulation at the Max Planck Institute of Immunobiology and Epigenetics. Akhtar was awarded EMBO membership in 2013. She became the first international and female Vice President of the Max Planck Society's Biology and Medicine Section in July 2020.

<span class="mw-page-title-main">Jürgen Knoblich</span> German molecular biologist

Jürgen Knoblich is a German molecular biologist. Since 2018, he is Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.  

Daniel Wolfram Gerlich is a cell biologist. Since 2012 he has been a Senior Group Leader at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.

Anne Ephrussi is a French developmental and molecular biologist. Her research is focused on the study of post-transcriptional regulations such as mRNA localization and translation control in molecular biology as well as the establishment of polarity axes in cell and developmental biology. She is head of the Developmental Biology Unit and director of the EMBL International Centre for Advanced Training (EICAT) program at the European Molecular Biology Laboratory (EMBL).

<span class="mw-page-title-main">Eileen Furlong</span> Irish molecular biologist

Eileen E. M. Furlong is an Irish molecular biologist working in the fields of transcription, chromatin biology, developmental biology and genomics. She is known for her work in understanding how the genome is regulated, in particular to how developmental enhancers function, how they interact within three dimensional chromatin topologies and how they drive cell fate decisions during embryogenesis. She is Head of the Department of Genome Biology at the European Molecular Biology Laboratory (EMBL). Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, the Academia Europaea in 2016 and to EMBO’s research council in 2018.

<span class="mw-page-title-main">Andrea Pauli</span> German developmental biologist and biochemist

Andrea Pauli is a developmental biologist and biochemist studying how the egg transitions into an embryo, and more specifically the molecular mechanisms underlying vertebrate fertilisations, egg dormancy, and subsequent egg activation. Her lab uses zebrafish as the main model organism. Andrea Pauli is a group leader at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter in Austria.

References

  1. ↑ "Julius Brennecke - Team". IMBA - Institute of Molecular Biotechnology. Retrieved 2019-07-15.
  2. ↑ "Brennecke CV" (PDF).
  3. ↑ "One experiment: When genome defense against transposons fails". Cold Spring Harbor Laboratory. 2009-05-29. Retrieved 2019-11-21.
  4. ↑ "Find people in the EMBO Communities". people.embo.org. Retrieved 2019-11-21.
  5. ↑ Press, Rockefeller University (2015-11-23). "New editorial board members". The Journal of Cell Biology. 211 (4): 723–727. doi:10.1083/jcb.201511023. ISSN   0021-9525. PMC   4657179 . PMID   26598609.
  6. ↑ "PCR alternative: RT-LAMP, a new SARS-CoV-2 test "Made in Vienna"". Vienna BioCenter. 21 October 2020. Retrieved 2020-10-22.
  7. ↑ "Coronavirus - Schneller "LAMP"-Nachweis vor breiter Anwendung". plus.oe24.at. 2020-10-21. Retrieved 2020-10-22.
  8. ↑ "Coronavirus - Schneller LAMP-Nachweis vor breiter Anwendung". science.apa.at (in German). Retrieved 2020-10-22.
  9. ↑ "Julius Brennecke - Google Scholar Citations". scholar.google.com. Retrieved 2019-07-16.
  10. ↑ "58 research works produced by Julius Brennecke | IMBA Institute Of Molecular Biotechnology, Vienna and other places". ResearchGate. Retrieved 2019-07-16.
  11. ↑ "Alumni Awards - The John Kendrew Award - EMBL". www.embl.de. Retrieved 2019-11-21.
  12. ↑ "Brennecke Premio Leonardo" (PDF).
  13. ↑ "ERC-Starting Grant an Julius Brennecke - derStandard.at". DER STANDARD (in Austrian German). Retrieved 2019-11-21.
  14. ↑ "Find people in the EMBO Communities". people.embo.org. Retrieved 2019-11-21.
  15. ↑ "ERC CONSOLIDATOR GRANT FOR JULIUS BRENNECKE". www.oeaw.ac.at. Retrieved 2019-11-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.